| Primary |
| Drug Use For Unknown Indication |
42.3% |
| Hypertension |
30.7% |
| Product Used For Unknown Indication |
7.7% |
| Cardiomyopathy |
3.0% |
| Cardiac Failure Congestive |
3.0% |
| Left Ventricular Dysfunction |
2.5% |
| Atrial Fibrillation |
2.1% |
| Cardiac Failure |
1.3% |
| Cardiac Disorder |
1.2% |
| Blood Pressure |
0.9% |
| Asthma |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Myocardial Infarction |
0.7% |
| Arrhythmia |
0.7% |
| Prophylaxis |
0.5% |
| Heart Rate Decreased |
0.4% |
| Depression |
0.4% |
| Prophylaxis Against Transplant Rejection |
0.4% |
| Supplementation Therapy |
0.4% |
| Tachycardia |
0.4% |
|
| Weight Increased |
10.0% |
| Fatigue |
10.0% |
| Death |
8.2% |
| Drug Ineffective |
7.7% |
| Hypotension |
6.2% |
| Dizziness |
6.0% |
| Dyspnoea |
6.0% |
| Vision Blurred |
5.1% |
| Alopecia |
4.7% |
| Rash |
4.5% |
| Somnolence |
4.4% |
| Syncope |
3.9% |
| Heart Rate Decreased |
3.2% |
| Myocardial Infarction |
3.2% |
| Visual Disturbance |
3.2% |
| Nausea |
2.8% |
| Vomiting |
2.8% |
| Malaise |
2.7% |
| Oedema Peripheral |
2.7% |
| Palpitations |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.7% |
| Product Used For Unknown Indication |
20.2% |
| Hypertension |
18.7% |
| Cardiac Failure Congestive |
4.5% |
| Cardiac Disorder |
3.9% |
| Diabetes Mellitus |
3.1% |
| Asthma |
2.8% |
| Prophylaxis |
2.7% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.9% |
| Back Pain |
1.8% |
| Benign Prostatic Hyperplasia |
1.5% |
| Rheumatoid Arthritis |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Lung Neoplasm Malignant |
1.3% |
| Premedication |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Emphysema |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Hypothyroidism |
1.2% |
|
| Weight Increased |
10.2% |
| Syncope |
9.8% |
| Vomiting |
9.8% |
| Wheezing |
8.5% |
| Drug Hypersensitivity |
6.0% |
| Hypotension |
5.1% |
| Dizziness |
4.7% |
| Overdose |
4.7% |
| Vascular Occlusion |
4.3% |
| Myocardial Infarction |
3.8% |
| Pneumonia |
3.8% |
| Weight Decreased |
3.8% |
| Drug Ineffective |
3.4% |
| Fatigue |
3.4% |
| Nausea |
3.4% |
| Oedema Peripheral |
3.4% |
| Death |
3.0% |
| Headache |
3.0% |
| Rash |
3.0% |
| Visual Disturbance |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.2% |
| Drug Use For Unknown Indication |
22.3% |
| Hypertension |
8.9% |
| Cardiac Disorder |
3.5% |
| Diabetes Mellitus |
3.5% |
| Atrial Fibrillation |
3.4% |
| Blood Cholesterol Increased |
2.6% |
| Pain |
2.4% |
| Cardiac Failure Congestive |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Depression |
1.5% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Multiple Myeloma |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Prophylaxis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Osteoporosis |
1.1% |
| Blood Pressure |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Anxiety |
1.0% |
|
| Vomiting |
12.5% |
| Weight Decreased |
11.9% |
| Weight Increased |
8.6% |
| Myocardial Infarction |
8.0% |
| Death |
5.5% |
| Nausea |
5.0% |
| Drug Ineffective |
4.5% |
| Flushing |
4.3% |
| Urinary Tract Infection |
4.2% |
| Pain |
4.1% |
| Vision Blurred |
3.5% |
| Ventricular Tachycardia |
3.4% |
| Pruritus |
3.3% |
| Renal Failure |
3.3% |
| Renal Failure Acute |
3.2% |
| Dyspnoea |
3.1% |
| Rash |
3.0% |
| Unevaluable Event |
2.9% |
| Oedema Peripheral |
2.8% |
| Pain In Extremity |
2.8% |
|
| Interacting |
| Cardiac Disorder |
19.2% |
| Hypertension |
11.5% |
| Depression |
7.7% |
| Diabetes Mellitus |
7.7% |
| Pain |
7.7% |
| Anticoagulant Therapy |
3.8% |
| Blood Cholesterol Increased |
3.8% |
| Dyspepsia |
3.8% |
| Dyspnoea |
3.8% |
| Hypercholesterolaemia |
3.8% |
| Hypothyroidism |
3.8% |
| Infection |
3.8% |
| Panic Attack |
3.8% |
| Postoperative Care |
3.8% |
| Prophylaxis |
3.8% |
| Smoking Cessation Therapy |
3.8% |
| Thyroid Disorder |
3.8% |
|
| Drug Interaction |
33.3% |
| Cardiac Disorder |
16.7% |
| Overdose |
16.7% |
| Urticaria |
16.7% |
| Vertigo |
16.7% |
|
